Results of the Pivotal STORM Study (Part 2) in Penta-Refractory Multiple Myeloma (MM): Deep and Durable Responses with Oral Selinexor Plus Low Dose Dexamethasone in Patients with Penta-Refractory MM
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Ajai Chari, Dan T. Vogl, Meletios A Dimopoulos, Ajay K Nooka, Carol Ann Huff, Philippe Moreau, Craig E. Cole, Joshua Richter, David Dingli, Ravi Vij, Sascha A Tuchman, Marc S Raab, Katja Weisel, Michel Delforge, David Kaminetzky, Robert Frank Cornell, A Keith Stewart, James Hoffman, Kelly N. Godby, Terri L Parker, Moshe Levy, Martin Schreder, Nathalie Meuleman, Laurent Frenzel, Mohamad Mohty, Choquet Sylvain, Andrew J. Yee, Maria Gavriatopoulou, Luciano J Costa, Jatin J. Shah, Carla Picklesimer, Jean-Richard Saint-Martin, Lingling Li, Michael G. Kauffman, Sharon Shacham, Paul Richardson, Sundar Jagannath
Institutions: Icahn School of Medicine at Mount Sinai, Abramson Cancer Center, University of Pennsylvania, National and Kapodistrian University of Athens, Emory University, Winship Cancer Institute, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Centre Hospitalier Universitaire de Nantes, Nantes Université, University of Michigan, Mayo Clinic, Washington University in St. Louis, University of North Carolina at Chapel Hill, University Hospital Heidelberg, Universitätsklinikum Tübingen, Universitair Ziekenhuis Leuven, NYU Langone Health, Vanderbilt University, Vanderbilt University Medical Center, Mayo Clinic in Arizona, University of Miami, University of Alabama at Birmingham, Yale University, Baylor University, Universitätsklinikum Würzburg, Institut Jules Bordet, Hôpital Necker-Enfants Malades, Hôpital Saint-Antoine, Pitié-Salpêtrière Hospital, Massachusetts General Hospital, Karyopharm Therapeutics (United States), Harvard University, Dana-Farber Cancer Institute, Mount Sinai Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2918524720